Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 2 (February)

1. Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy.
   Radiother Oncol, 74(1): 71-3. [Abstract] [Full-text]
2. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
   Cancer, 103(3): 616-24. [Abstract] [Full-text]
3. Sun exposure and mortality from melanoma.
   J Natl Cancer Inst, 97(3): 195-9. [Abstract] [Full-text]
4. PUMA expression is significantly reduced in human cutaneous melanomas.
   Oncogene, 24(6): 1111-6. [Abstract] [Full-text]
5. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions.
   Cancer Immunol Immunother, 54(1): 61-6. [Abstract] [Full-text]
6. Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice.
   Cancer Immunol Immunother, 54(4): 345-50. [Abstract] [Full-text]
7. Imiquimod in the treatment of extensive recurrent lentigo maligna.
   J Am Acad Dermatol, 52(2): 51-2. [Abstract] [Full-text]
8. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.
   J Am Acad Dermatol, 52(2): 197-203. [Abstract] [Full-text]
9. Glycerophosphoinositols inhibit the ability of tumour cells to invade the extracellular matrix.
   Eur J Cancer, 41(3): 470-6. [Abstract] [Full-text]
10. Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
    Eur J Cancer, 41(3): 386-92. [Abstract] [Full-text]
11. Colors in atypical nevi: a computer description reproducing clinical assessment.
    Skin Res Technol, 11(1): 36-41. [Abstract] [Full-text]
12. Predictive power of irregular border shapes for malignant melanomas.
    Skin Res Technol, 11(1): 1-8. [Abstract] [Full-text]
13. Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members.
    Cancer Immunol Immunother, 54(4): 359-71. [Abstract] [Full-text]
14. Evaluation of tumor-specific promoter activities in melanoma.
    Gene Ther, 12(4): 330-8. [Abstract] [Full-text]
15. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
    Curr Biol, 15(3): 249-54. [Abstract] [Full-text]
16. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
    Gene Ther, 12(4): 339-46. [Abstract] [Full-text]
17. Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.
    Cancer Immunol Immunother, 53(12): 1111-8. [Abstract] [Full-text]
18. Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomography.
    Eur J Surg Oncol, 31(2): 197-204. [Abstract] [Full-text]
19. Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.
    Arch Dermatol Res, 296(8): 353-8. [Abstract] [Full-text]
20. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
    Arch Dermatol Res, 296(8): 345-52. [Abstract] [Full-text]
21. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
    Hum Gene Ther, 16(1): 91-100. [Abstract] [Full-text]
22. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
    Hum Gene Ther, 16(1): 35-48. [Abstract] [Full-text]
23. Primary malignant melanoma of the urethra.
    Urology, 65(2): 389. [Abstract] [Full-text]
24. Tyrosinase-related protein-2 and -1 are trafficked on distinct routes in B16 melanoma cells.
    Biochem Biophys Res Commun, 328(4): 914-21. [Abstract] [Full-text]
25. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications.
    Cancer Treat Rev, 31(1): 18-26. [Abstract] [Full-text]
26. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis.
    Exp Cell Res, 304(1): 244-55. [Abstract] [Full-text]
27. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity.
    J Biol Chem, 280(7): 5812-9. [Abstract] [Full-text]
28. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
    Hum Pathol, 36(1): 74-81. [Abstract] [Full-text]
29. Views of UK melanoma patients on routine follow-up care.
    Br J Plast Surg, 58(2): 245-50. [Abstract] [Full-text]
30. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.
    Cancer, 103(4): 780-7. [Abstract] [Full-text]
31. Absence of V599E BRAF mutations in desmoplastic melanomas.
    Cancer, 103(4): 788-92. [Abstract] [Full-text]
32. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Int J Cancer, 114(4): 513-21. [Abstract] [Full-text]
33. Bowes melanoma cells secrete heregulin, which can promote aggregation and counteract invasion of human mammary cancer cells.
    Int J Cancer, 114(4): 572-8. [Abstract] [Full-text]
34. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
    Int J Cancer, 114(3): 426-32. [Abstract] [Full-text]
35. Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth.
    Int J Cancer, 114(3): 356-63. [Abstract] [Full-text]
36. Altered expressions of HOX genes in human cutaneous malignant melanoma.
    Int J Cancer, 114(3): 436-41. [Abstract] [Full-text]
37. A peptide derived from melanocytic protein gp100 and presented by HLA-B35 is recognized by autologous cytolytic T lymphocytes on melanoma cells.
    Tissue Antigens, 65(2): 156-62. [Abstract] [Full-text]
38. Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor.
    Cancer Gene Ther, 12(3): 268-75. [Abstract] [Full-text]
39. A comparison of colour micrographs obtained with a charged couple device (CCD) camera and a 35-mm camera.
    Acta Ophthalmol Scand, 83(1): 89-93. [Abstract] [Full-text]
40. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells.
    Oncogene, 24(8): 1309-19. [Abstract] [Full-text]
41. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
    Oncogene, 24(8): 1423-33. [Abstract] [Full-text]
42. Psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study.
    J Clin Oncol, 23(6): 1270-7. [Abstract] [Full-text]
43. Molecular staging in stage II and III melanoma patients and its effect on long-term survival.
    J Clin Oncol, 23(6): 1218-27. [Abstract] [Full-text]
44. Cutaneous melanoma: pathogenesis and rationale for chemoprevention.
    Crit Rev Oncol Hematol, 53(3): 225-39. [Abstract] [Full-text]
45. Cutaneous melanoma.
    Lancet, 365(9460): 687-701. [Abstract] [Full-text]
46. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2.
    Biochem Biophys Res Commun, 329(1): 266-74. [Abstract] [Full-text]
47. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
    Ann Oncol, 16(3): 460-5. [Abstract] [Full-text]
48. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.
    J Biol Chem, 280(8): 6950-9. [Abstract] [Full-text]
49. Ultrasound scanning in dermatology.
    Arch Dermatol, 141(2): 217-24. [Abstract] [Full-text]
50. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma.
    Arch Dermatol, 141(2): 183-9. [Abstract] [Full-text]
51. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Arch Dermatol, 141(2): 177-80. [Abstract] [Full-text]
52. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Arch Dermatol, 141(2): 165-73. [Abstract] [Full-text]
53. Limitations of dermoscopy in the recognition of melanoma.
    Arch Dermatol, 141(2): 155-60. [Abstract] [Full-text]
54. Microscopic in vivo description of cellular architecture of dermoscopic pigment network in nevi and melanomas.
    Arch Dermatol, 141(2): 147-54. [Abstract] [Full-text]
55. Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.
    Br J Cancer, 92(4): 673-80. [Abstract] [Full-text]
56. Oral exposure to atrazine modulates cell-mediated immune function and decreases host resistance to the B16F10 tumor model in female B6C3F1 mice.
    Toxicology, 209(1): 15-28. [Abstract] [Full-text]
57. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Br J Cancer, 92(4): 662-7. [Abstract] [Full-text]
58. Incidence of noncutaneous melanomas in the U.S.
    Cancer, 103(5): 1000-7. [Abstract] [Full-text]
59. Dermoscopy for early detection of facial lentigo maligna.
    Br J Dermatol, 152(2): 361-4. [Abstract] [Full-text]
60. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
    Magn Reson Med, 53(3): 621-7. [Abstract] [Full-text]
61. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    J Magn Reson Imaging, 21(3): 272-81. [Abstract] [Full-text]
62. Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.
    Int Immunol, 17(3): 257-68. [Abstract] [Full-text]
63. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
    J Neurooncol, 71(3): 307-13. [Abstract] [Full-text]
64. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    J Clin Oncol, 23(7): 1473-82. [Abstract] [Full-text]
65. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Cancer Res, 65(4): 1570-6. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.